246 related articles for article (PubMed ID: 19522023)
1. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J
World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
[TBL] [Abstract][Full Text] [Related]
5. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
7. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
[TBL] [Abstract][Full Text] [Related]
9. [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
Ran JT; Zhou YN; Tang CW; Lu JR; Wu J; Lu H; Yang GD
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):448-51. PubMed ID: 19024521
[TBL] [Abstract][Full Text] [Related]
10. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
[TBL] [Abstract][Full Text] [Related]
11. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
Aziz F; Yang X; Wang X; Yan Q
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1221-35. PubMed ID: 25527419
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib inhibits Helicobacter pylori-induced invasion of gastric cancer cells through an adenine nucleotide translocator-dependent mechanism.
Lan C; Yang L; Fan L; Zhang Y; Wang J; Guo GJ; Wan S; Yang S; Wang R; Fang D
Anticancer Agents Med Chem; 2013 Oct; 13(8):1267-72. PubMed ID: 23574384
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of
Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
[TBL] [Abstract][Full Text] [Related]
15. Long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia After H. pylori eradication.
Sheu BS; Tsai YC; Wu CT; Chang WL; Cheng HC; Yang HB
Helicobacter; 2013 Apr; 18(2):117-23. PubMed ID: 23067366
[TBL] [Abstract][Full Text] [Related]
16. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Lee CW; Rickman B; Rogers AB; Ge Z; Wang TC; Fox JG
Cancer Res; 2008 May; 68(9):3540-8. PubMed ID: 18441088
[TBL] [Abstract][Full Text] [Related]
18. Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
Hung KH; Yang HB; Cheng HC; Wu JJ; Sheu BS
J Gastroenterol Hepatol; 2010 Jan; 25(1):48-53. PubMed ID: 19793174
[TBL] [Abstract][Full Text] [Related]
19. Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Mansour-Ghanaei F; Joukar F; Mojtahedi K; Sokhanvar H; Askari K; Shafaeizadeh A
Asian Pac J Cancer Prev; 2015; 16(4):1571-4. PubMed ID: 25743833
[TBL] [Abstract][Full Text] [Related]
20. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.
Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ
Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]